Nuclease for degrading residual DNA and RNA in biological process streams, supporting lower viscosity, clearer clarification, and downstream purification compatibility.
Request pricingResidual DNA and RNA can turn a workable biological process stream into a difficult one. Released nucleic acids increase viscosity, slow clarification, load filters, and complicate downstream purification behavior.
Strandfall Nuclease is specified for controlled degradation of DNA and RNA in bioprocessing workflows where process clarity, manageable fluid behavior, and downstream compatibility matter.
During cell disruption, fermentation, harvest, or intermediate handling, nucleic acids may be released into the liquid phase. Nuclease breaks these long DNA and RNA strands into smaller fragments, helping reduce the physical and purification burden associated with intact nucleic acids.
For downstream teams, the operational goal is simple: a process stream that moves, clarifies, filters, and purifies with fewer nucleic-acid-driven complications.
Strandfall Nuclease is commonly evaluated in workflows involving:
The enzyme is typically introduced where nucleic acid release is expected and where the process can provide adequate mixing, contact time, and compatible conditions.
Nuclease is not only a biochemical input. In a production workflow, it is a control point for process handling.
Potential outcomes include:
Performance depends on the matrix, process conditions, impurity profile, and point of addition. Strandfall supports application-level evaluation so teams can define the right use pattern for their own workflow.
When specifying nuclease for bioprocessing, buyers usually need more than a product name. They need lot confidence, documentation, and supply alignment.
Key purchasing considerations include:
Strandfall focuses on the practical intersection of enzyme performance and procurement execution: the material must work in the stream, arrive reliably, and support repeatable manufacturing decisions.
For development teams, nuclease evaluation should be planned around the process matrix rather than treated as a generic additive. Important variables include the timing of addition, mixing strategy, nucleic acid load, contact window, and downstream removal or compatibility expectations.
A useful evaluation plan often compares treated and untreated streams for handling behavior, clarification response, filtration pressure behavior, and downstream purification impact. The target is not academic confirmation of enzyme action. The target is a more controlled process stream.
Strandfall Nuclease helps convert nucleic-acid-heavy material into a more manageable feed for recovery and purification. That can reduce avoidable friction between upstream release and downstream separation.
If residual DNA or RNA is affecting viscosity, clarification, filtration, or purification performance, Strandfall can help you assess fit, packaging, documentation, and supply options.
Use the form below to request pricing, discuss volumes, or ask for application support for a bioprocessing workflow.



Tell us your application and volume — we reply with pricing and lead time.